Top Stories News
Top Top Stories News
-
.png)
News Women in Pharma: Our hopes for 2025 and beyond
Our last instalment for 2024 of the Women in Pharma series brings you messages direct from the Informa Markets CPHI team as they discuss the advice and insights they have carried throughout their roles working at CPHI, and what they hope to see for the... -
News CPHI Milan 2024 - From the Floor
Milan and CPHI welcome you to 2024 CPHI Milan! As we celebrate the 35th edition of our flagship CPHI show, editors Vivian Xie and Lucy Chard bring you the latest from the show floor, conference sessions, and innovative solutions from all exhibitors, at...
Top Stories news
-
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News A Day in the Life of a Global CDMO Chapter Lead – Manufacturing
The 'Day in the Life of' series has covered many aspects of the pharmaceutical pipeline, including R&D and procurement, now we're taking a look at manufacturing from a global CDMO perspective. -
News CPHI Milan Speaker Spotlight: CDMO relations with Pharma and Start-Ups
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
.png)
News Women in Pharma: Advocating for trans healthcare in pharma
In our monthly series on women in the pharmaceutical industry, we interview leading experts in the pharmaceutical supply and value chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Updated – Changing abortion pill access according to the US FDA and Supreme Court
After the approval of the medical abortion pill, mifepristone, by the US FDA, states across the USA approach the distribution of the pill differently, some ruling against allowing access to the drug. -
News CPHI North America 2024 – From the Floor
Welcome to Philly! CPHI North America once again graces the Philadelphia Convention Center, 7–9 May 2024. -
.png)
News Drug Patent Expiries: a steep cliff or opportunity for innovation?
The pharmaceutical industry faces a patent cliff together in the years leading up to 2030. Learn what this means for drug pricing, their outsourcing partners, and drug innovation of the future. -
News A Day in the Life of a President and Chief Scientific Officer
We are continuing to get to know the people working day-to-day behind the pharma companies shaping the industry, the ones who keep the wheels turning and ultimately bring better healthcare to the population; we are talking to the individuals at the hea... -
.png)
News Gerresheimer predicts weight-loss drug deals to account for 4% of yearly growth
Dietmar Siemssen, CEO of German primary packaging manufacturer Gerresheimer, states that approximately 4% of the company’s revenue growth each year to come from deals with drugmakers of weight loss and diabetes products, particularly GLP-1 class ... -
News LEAP-ing into the future of pharma – the CPHI Middle East Vision
On March 6, 2024, the CPHI team hosted the Future of Pharma Forum at LEAP 2024, Saudi Arabia’s premier destination for tech leaders and innovators to meet and collaborate. -
.png)
News Informa Markets International Women’s Day Panel Discussion
On March 7, 2024, the Informa Markets Amsterdam office hosted an International Women’s Day Breakfast and Panel Discussion to celebrate the women who drive the B2B events industry forward, including members of the CPHI team. -
.png)
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News CPHI Middle East 2024 – What do we have to look forward to?
We’re bringing CPHI to the Middle East in December 2024. CPHI brings together the pharma community from all over the world, creating a platform for education, collaboration, and progress. -
.png)
News US FDA approves three different oncology drugs in 1 week
In the last week, the US FDA has granted approval/accelerated approval to three different oncology drugs, each from different drugmakers with different indications. -
.png)
News 5 African American Pharmaceutical Pioneers: Honouring Black History Month
In recognition of February as Black History Month in the United States, we cover the lives and works of five pioneering African American pharmaceutical professionals who have contributed significantly to the world of pharmaceuticals and drug devel... -
News A Day in the Life of a Procurement Specialist
To get to know the people working day to day behind our pharma companies, the ones who keep the wheels turning and ultimately bring better healthcare to the population, we are talking to the individuals at the heart of pharma. -
.png)
News What the Novo Holdings and Catalent deal means for pharma outsourcing
On February 5, 2024, Novo Holdings announced their intention to acquire pharma and biotech CDMO Catalent at US$16.5 billion. Read more about what this means for the pharmaceutical industry as a whole, from drugmakers to their partners in manufacturing.... -
.png)
News Pharmapack Awards 2024 Packaging Innovation Award Winner – Nissha Europe GmbH
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Special Edition Women in Pharma: International Day of Women and Girls in Science
In this monthly series, we bring insightful content, events, and communities dedicated to sharing best practices for DE&I strategies and showcasing underrepresented voices in the pharmaceutical community. -
News Pharmapack Awards 2024 Start-up Innovation Award Winner – Capa Valve Ltd
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Hiring Across the Gender Divide
In our monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
.png)
Sponsored Content Ashwagandha and Herbal Medicines: Pharma’s Next Opportunity
Herbal medicines and nutraceuticals have seen a surge in interest since the onset of the COVID-19 pandemic. Driven by patient interest in prioritising personalised and integrative medicines, the herbal ingredients industry is now faced with concerns pe... -
News Identifying Alzheimer’s Disease biomarker proteins with whole blood tests
A University of Manchester spin-out pharmaceutical company, PharmaKure, has reported successful study results for the quantification of Alzheimer’s Disease biomarker proteins with a whole blood test. -
News Bill & Melinda Gates Foundation to boost mRNA vaccine initiatives in Africa with USD $40m
To address vaccine inequality and accessibility issues, the Bill & Melinda Gates Foundation aims to deliver USD $40m to various biotech companies and vaccine manufacturers in support of mRNA vaccine development. -
News Revolutionising cancer treatment with mRNA-based therapeutics
Global market for mRNA-based oncology therapeutics expected to reach USD $2 billion by 2029, with promising results for the combination of mRNA candidates with immune checkpoint inhibitors to treat solid tumours. -
News Choosing the Right CDMO Partner: A Comprehensive Guide
Finding the right partner for the development and manufacturing of your pharmaceutical or biopharmaceutical products is paramount. This is where Contract Development and Manufacturing Organizations (CDMOs) step in, offering their expertise and infrastr... -
News Breaking Barriers: Innovations in Oral Solid Dose Form Bioavailability
The effectiveness of a medication often hinges on its bioavailability – the rate and extent at which the active ingredient is absorbed into the bloodstream. When it comes to oral solid dose forms, such as tablets and capsules, the challenge lies ... -
News Bringing the pharmaceutical supply chain closer to home
The pharmaceutical supply chain has encountered numerous disruptions in the last few years, impacting procurement, manufacturing, packaging, and distribution operations within the pharmaceutical industry. Read about the rise in calls for near/resh... -
News Women in Pharma: Advancing gender diversity & healthcare equality
In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Humira biosimilars at discounted prices to meet market demand for accessible treatment
Several biosimilars to AbbVie’s monoclonal antibody therapeutic Humira were launched by various pharmaceutical giants this week in the US, with more expected to be released by the end of the year as the patent expires. -
News Women in Pharma: Gearing up for systemic change
In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Delivering on mRNA-based therapeutics: innovations in applications and packaging
Since the onset of the COVID-19 pandemic, the innovative potential of mRNA vaccines and therapeutics has raised questions regarding their manufacturing, packaging, and storage/transportation. Learn about how the pharmaceutical supply chain is meet... -
News Novavax will provide adjuvant Matrix-M for vaccine research with 3-year partnership
Novavax, developers behind the Matrix-M adjuvant, have entered into an agreement with the Bill and Melinda Gates Medical Research Institute to provide the adjuvant in preclinical vaccine research. -
News CPHI Online Webinar Series – The CPO Perspective: Driving Healthcare Sustainability
Pharmaceutical contract packaging organisations (CPOs) offer organisations broader expertise in pharma packaging, specialist skills, and flexibility with time, efficiency, and costings for pharmaceutical companies lacking in-house packaging expert... -
News The CPO Starter Pack: Why and When to Bring in a Contract Packaging Partner
Discover the trends affecting the pharmaceutical CPO market, when and why outsourcing may be an enticing option, and what is driving pharmaceutical companies and CDMOs to partner with outsourced packaging and drug delivery organisations. ... -
News Medicines for All receive $18.7 million grant for expansion of global access to lifesaving medication
Funded by the Bill & Melinda Gates Foundation, the Virginia Commonwealth University-based research-related institute will use the grant to expand on its current capabilities of bringing lifesaving medications around the world, as well as working on 14 ... -
.png)
News CPHI North America Anniversary Ball – celebrating The Art of Pharma
This year marks the 5th anniversary of CPHI North America regional events. To celebrate this remarkable achievement, the CPHI show team hosted The Art of Pharma Anniversary Ball at the illustrious Philadelphia Museum of Art, with a keynote speech from ... -
News CPHI North America 2023 – From the Floor
Follow along for live updates from the Content team as we bring you the latest from CPHI North America 2023 - from session talks, panel discussions, interviews, and more, there's a lot to discover with CPHI Online at the Pennsylvania Convention Cen... -
News To recruit or to retain - where is the pharma talent going?
Discover how the pharmaceutical workforce has evolved past the pandemic, and the challenges faced by the pharma industry during a talent acquisition and retention crisis. -
News Doctors Without Borders demands transparency from GSK on licensing agreements for preventative HIV treatment
GSK has signed licensed agreements with three companies to manufacture generic versions of its preventative HIV medicine for distribution in lower-income countries but calls for increased transparency is putting pressure on the drugmaker. -
News Pfizer acquires Seagen to become the leading innovator in cancer therapy
Pfizer makes a bold move in the acquisition of innovative cancer therapy biotechnology company Seagen, the move means the doubling of their pipeline of early-stage therapeutics and gaining four leading ADC therapies. -
News Women in Pharma – Sukhada Chaturvedi Pharmapack 2023
This year at Pharmapack 2023, we interviewed several leading women in the pharmaceutical industry about what it means to be a woman working in pharma. In the lead-up to International Women’s Day on March 8, 2023, CPHI Online is proud to highlight... -
News CPHI Webinar Series – The Big Questions: Pharmaceutical Packaging, Sustainability and Circularity
With growing awareness for sustainable industry practices within pharmaceuticals, pharma packaging companies are facing pressures to balance drug efficacy, patient safety, supply chain security, and sustainability. Speakers Sriman Banerjee, Head of Pac... -
News Gender equity in pharma - celebrating historic women in pharma
As we continue to celebrate the contributions of women in the pharmaceutical field following International Day of Women and Girls in Science and in the lead up to International Women’s Day on March 8, 2023, we take a look at some of the historic ... -
News Gender equity in pharma– beyond the boardroom
Three reasons why advancing gender equity in healthcare should be a priority for pharma -
News The HPAPI supply chain: why manufacturers should care about handling and transportation
An increasing number of drug development pipelines are turning towards the use of HPAPIs to target rare and ‘undruggable’ diseases. In this article, we talk to leading industry experts about how pharmaceutical manufacturers are adapting and... -
News CARBOGEN AMCIS opens new liquid drug product manufacturing facility
The Switzerland-based pharmaceutical process and ingredient developer and manufacturer announced the opening of their new sterile liquid drug product manufacturing facility in France. -
News Pfizer expands ‘An Accord for a Healthier World’ program to bridge global health equity gap
An expansion of Pfizer’s not-for-profit health equity program will offer up to 500 patented and off-patent products to 45 lower-income countries, building on their initial offering of patented medicines and vaccines in the US and EU. -
News Anima Biotech brings mRNA biology modulators to AbbVie against oncology and immunology targets
A USD $42 million collaboration between AbbVie and Anima Biotech aims to leverage the latter’s mRNA Lightning technology platform to enhance therapeutic development programs in oncology and immunology. -
News Algorithm accelerated: machine-learning may reduce drug formulation development times
Machine-learning models demonstrate the potential to accelerate drug formulation discovery and development for long-acting injectables. -
.png)
News Moderna to buy OriCiro Genomics in USD $85 million deal
Pharmaceutical company Moderna acquires genomics services company OriCiro Genomics, based in Tokyo, Japan, to boost mRNA therapeutics development and manufacturing portfolio. -
News New year, new prices: at least 350 drugs in USA to see price increases in January
Drugmakers such as Pfizer, GSK, BMS, AstraZeneca, and Sanofi are planning to raise prices for at least 350 unique drugs in the United States in early January. -
Sponsored Content Pharma Trend Outlook: Pharma 4.0 and Industry Resilience
Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain. -
News CPHI Frankfurt: Interview with Marcelo Cruz, Vice President, Business Development & Marketing at Tjoapack
In this series of interviews, we caught up with some of the exhibitors at CPHI Frankfurt to discover what innovations are being brought to the pharmaceutical industry this year. Here we chat with Marcelo Cruz of Tjoapack to discuss how global events ar... -
.png)
News Strategic partnership between AstraZeneca and G42 Healthcare to increase pharmaceutical manufacturing in Abu Dhabi
A comprehensive, long-term partnership agreement between AstraZeneca and G42 Healthcare is set to enhance local drug manufacturing in Abu Dhabi, UAE, and bolster pharmaceutical manufacturing innovation within the country. -
.png)
News Trend Report: The True Cost of API Price Rises
Download our Trend Report to discover what the current landscape of APIs and their pricing means for the pharmaceutical industry in the future. -
News Alzheimer's drug lecanemab shows reduced cognitive decline in clinical trial
A monoclonal antibody drug, named lecanemab, has been tested in a Phase III clinical trial in nearly 1800 participants, with promising results in reducing the effects of Alzheimer's disease on the brain. -
News CPHI Frankfurt 2022: Innovator Interview – Procaps Group
In this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We interviewed Rosella Del Vecchio Herrera, Marketing Director at Procaps Group, to discover h... -
.png)
News Biovac partnership to increase African vaccine manufacturing capabilities
South African biopharma company Biovac signs a partnership deal with the International Vaccine Institute to develop and manufacture an oral cholera vaccine for both the African and global market. -
.png)
News New vaccine technology utilising weakened DNA viruses
A new method of vaccine technology that employs weakened viruses has been developed to target DNA viruses that reproduce by making copies of their own DNA molecules, utilising a virus with altered DNA to fight against them. -
News CPHI Frankfurt 2022: Innovator Interview – Terumo
In this series of interviews, we speak to the companies on the CPHI Frankfurt show floor who are driving innovation in pharma for a better healthcare future. We chatted to Marco Chiadò Piat (President) and Anil Busimi (VP Strategy and Marketing)... -
News Sandoz to invest EUR €50 million in Austrian manufacturing facility for essential antibiotics
Sandoz, a leader in generic pharmaceutical and biosimilars, have announced their intentions to invest EUR €50 million in support of a technology upgrades at their Austrian manufacturing site to support increasing penicillin demands. -
News Blood cancer drug from GSK fails main goal of trial
GSK has released a statement on the failure of Blenrep in achieving the main goals of a late-stage study for the blood cancer therapeutic, raising concerns of regulatory approval being rescinded. -
.png)
News Aragen’s formulation manufacturing facility to begin operations in 2023
Aragen is set to open their new manufacturing facility at their Mallapur campus in Hyderabad, India in January 2023, enhancing the company’s ability to provide scaled manufacturing solutions and clinical supplies to their customers. -
.png)
News Partnership between Scitara and Veeva to bring optimised QC lab productivity to customers
Scitara and Veeva have announced a partnership to bring improved data infrastructures to the quality control process of drug and therapeutic market release. -
News Expansion of Quotient Sciences’ Alnwick, UK manufacturing facility complete
The major expansion of Quotient Sciences’ drug substance manufacturing facility in Alnwick has been completed, promising increased manufacturing systems and capabilities. -
News LG Chem to acquire AVEO Oncology with USD $566 million investment
South Korean chemical company LG Chem is set to acquire AVEO Oncology, an oncology-focused biopharmaceutical company based in the USA, as part of an investment to increase its footprint in North America and expand its development and commercialisation ... -
News Purolite celebrates expansion of innovative bioprocessing facility in Wales
Purolite, an Ecolab company, marked the opening of a new Customer Experience Centre featuring hands-on interactive and educational displays, showcasing the company’s expanded bioprocessing solutions. -
News ChargePoint Technology and STERIS collaborate to bring sterile solutions for Evonik
Evonik will be provided with sterile solutions from a collaboration between ChargePoint Technology Group and STERIS, utilising ChargePoint’s AseptiSafe Bio Valve and STERIS’ bio-decontamination systems. -
News BioNTech to set up mRNA manufacturing hubs in Australia
BioNTech, co-developers of one of the first mRNA COVID-19 vaccines, have signed an agreement to create manufacturing hubs in and around the Australian Victoria state in a bid to increase the country’s mRNA manufacturing abilities. -
News CDMO - Health is a Joint Project: Connect to Frankfurt on-demand
In this Connect to Frankfurt session, Emanuele Agnese, Business Development Manager and Pietro Allegrini, R&D Director at Indena, present the ways in which a reliable manufacturing partner in the pursuit of better health outcomes for patients and pharm... -
News Provention Bio, Inc. and Sanofi collaboration for potential launch of Type I diabetes therapeutic
Provention Bio, Inc. have granted exclusive right of first negotiation to Sanofi in exchange for commercial resources in the United States for the potential approval and launch of monoclonal antibody therapeutic teplizumab. -
.png)
News Roquette expands plant-based excipient portfolio with Crest Cellulose acquisition
Crest Cellulose, an Indian excipient manufacturer, has been acquired by plant-based pharmaceutical excipient provider Roquette in a bid to increase the latter’s presence in the Asia Pacific region. -
.png)
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Accepting novel excipients for innovative drug development
With the rapid development and manufacturing of new drugs and therapeutics being pushed through the pipeline, excipient manufacturers are navigating a challenging landscape to meet the demand for new and novel excipients. -
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News Connect to Frankfurt - Five reasons to tune in
Get a jump-start on your CPHI Frankfurt experience with exclusive access to our online event platform. -
News WHO calls on public for ideas to rename monkeypox
‘Poxy McPoxface’, ‘TRUMP-22’, and ‘Mpox’ are just some of the suggestions submitted by the public -
News Chinese market represents ‘single greatest generational opportunity’ for Pharma
China’s pharmaceutical industry is changing from formerly generics-focused into one that emphasizes innovation, spurred by shifting government policy and an aging population. -
News Monkeypox Update: Vaccine shortage, sewage surveillance and global testing
As concern over the monkeypox outbreak continues to rise, we take a look at major developments from the first week of August. -
News The Data Revolution: How Real-World Evidence is Changing Pharma
A look at the companies extracting valuable insights from health data to accelerate clinical development and support regulatory decision making. -
News mRNA production partnership to scale-up COVID-19 vaccine development
GreenLight Biosciences and Samsung Biologics announce mRNA production partnership to scale mRNA vaccine production to a commercial level with Samsung's expanded mRNA drug substance manufacturing site. -
News CPHI Podcast Series: The importance of novel excipients for innovative drug development
The latest episode in the CPHI Podcast Series dives into the world of novel excipients and explores their importance for innovative drug development. -
News Novel method for organoid production and storage to accelerate drug development research
Researchers develop method to produce organoid materials for disease and drug development research. -
News ‘Red flags’ spark concern over validity of key Alzheimer’s research
Serious concerns have been raised about the quality of landmark Alzheimer’s research, undermining commonly held beliefs about the disease -
News WHO declares monkeypox a global health emergency in split vote
Nine members of the WHO’s expert committee voted against the designation, while six voted in favour -
News Vaccine industry must help fight monkeypox and secure supply chains
Monkeypox is unlikely to develop into another pandemic, according to the WHO. But the recent spread of the virus could still be a challenge for the vaccine industry. -
News Amazon teams up with Fred Hutchinson to launch cancer vaccine clinical trial
Fred Hutchinson is sponsoring the Phase 1 trial, while Amazon are contributing scientific and machine learning expertise -
News CPHI Podcast Series: The Supplements Market – From Slump to Surge
The latest instalment in the CPHI Podcast Series dives into the world of supplements and explores the impact of COVID-19 on this booming market -
News New CPHI report looks at CDMO outsourcing and partner selection
In The Future of Outsourcing - Strategies for Partner Selection, experts from across the pharma industry look at current trends impacting the contract services landscape and gauge the merits and drawbacks of the most common outsourcing strategies ... -
News South Korea's Seegene develops PCR test to detect monkeypox virus
Several countries are stepping up vaccination and testing as monkeypox cases continue to climb -
News Investors turn attention to biotechs with clear path to market
Companies that are further down the road to market are more attractive to investors than those in early development -
News Charles River opens new UK manufacturing facility to support cell & gene development
The new facility is set to quadruple the company's HQ plasmid DNA capacity -
News WHO says monkeypox not a health emergency, but leaders ‘deeply concerned’
The UN agency convened a meeting last week to discuss the outbreak
-
News Pfizer hit with patent infringement lawsuit over COVID-19 drug Paxlovid
A US-based biotech is seeking damages for Pfizer’s use of a patented coronavirus 3CL protease inhibitor in its blockbuster drug Paxlovid -
News Valneva stock jumps as Pfizer invests more than €90M to support Lyme disease vaccine trial
VLA15 is the only Lyme disease vaccine candidate currently in clinical development -
News EMA starts rolling review of Moderna’s Omicron-targeting vaccine, as well as Pfizer-BioNTech rival
The vaccines have been adapted to target the Omicron variant, which has been the dominant variant globally since the beginning of the year -
News WHO to consider whether monkeypox should be classed as health emergency
A committee will meet next week to discuss issuing the emergency designation. -
News BioNTech to start work on first African mRNA vaccine factory this month
The Rwanda site will be the first piece of the company’s African manufacturing network -
News Niche start-ups spearheading cell and gene therapy innovation
Smaller companies targeting rare and extremely specific treatment areas are leading the charge in this emerging market. -
News CordenPharma Increases xRNA-based Capabilities at its Caponago Injectable Facility
CordenPharma, a full-service CDMO of APIs, Excipients, Drug Products & Packaging services, has increased its xRNA capabilities at its sterile injectable facility in Caponago, Italy. -
News How can pharma achieve ‘Net Zero’? Through driving change in pharma manufacturing
Through the entire product lifecycle – production, consumption and disposal – the pharma industry significantly impacts the environment. -
News Planning for supply chain resilience
Engagement-based strategy could increase resilience of pharma supply chain. -
News Updated: CPHI North America 2022 Blog
Follow along for live updates from CPHI North America, taking place in Philadelphia, PA from May 17-19. -
News Strategies for managing an outsourcing partner
Robust oversight linked to increased efficiency and better communication with outsourcing partners. -
News Pharmapack Awards 2022: Winners Revealed
The jury assessed a wide range of industry-changing innovations in packaging and drug delivery, ultimately selecting seven winners. -
News MedPharm: Increased investment driving developments in topical drugs market
We caught up with MedPharm at CPHI North America to discuss opportunities in the topical and transdermal products space. -
News Greater standardisation needed for effective ESG reporting - Expert panel
Increased transparency and standardisation in ESG reporting frameworks is emerging as a key requirement for investors. -
News What it means to be 'At the heart of Pharma'
Informa Markets colleagues explain the motivations behind CPHI’s rebrand. -
News CPHI Podcast Series: Leveraging data science for sustainable autoinjector development
Environmental impact is an area of increasing focus for the pharma and biopharma industries, with companies like Merck, Pfizer and GlaxoSmithKline setting ambitious targets for carbon neutrality and laying plans for waste reduction. -
News Thermo Fisher and Charles River join consortium using robotics to produce cell therapies at scale
The Consortium aims to increase the scale of cell therapy manufacturing to a level impossible with current manual processes. -
News Africa’s first COVID-19 vaccine plant receives no orders since launch
The first COVID-19 vaccine plant in Africa is at risk of closure due to lack of demand. -
News How is tech shaping pharma packaging and drug delivery?
For a full rundown on tech trends driving the sector, catch these five sessions at Pharmapack 2022 -
News Supply chain disruptions continue, but is the end in sight?
Supply chain disruptions have become the new normal. Recurring pandemic waves, inflation, trade jitters and a war in Europe have done little to quell C-suite anxieties. -
News Onyx Scientific expands small molecule CMC services with new UK facility
The contract development and manufacturing organisation (CDMO) has completed the first phase of its multi-million-pound development. -
News Roche latest to report trial delays due to Ukraine war
The war in Ukraine has forced companies to suspend or delay clinical trials in the region. -
News Pharmapack Review: Less is more for innovative pharma packaging
Pharmapack 2022 is just around the corner and judging for its annual awards is already underway. Every year a jury of industry experts assesses a range of products making waves in packaging and drug delivery and ultimately crowns a handful of winners a... -
News CPHI Podcast Series: Success in healthcare M&A, taking a people-first approach
Global mergers and acquisitions hit an all-time high in 2021, and in the life sciences industry these kinds of deals show no sign of slowing down. -
News CPHI Podcast Series: Connecting the user to your product – Smart packaging for smart devices
Smart devices are revolutionising how we live our lives and changing the shape of the industries adopting them. One such industry is healthcare, where the benefits of context-aware devices and real-time data sharing are having tangible effects on patie... -
News Moderna to build first mRNA vaccine manufacturing facility in Africa
Moderna announces up to USD $500 million investment for the construction of mRNA vaccine manufacturing facility in Kenya, the first of its kind on the African continent. The facility will be a significant step towards vaccine equity...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance